Harbour Investments, Inc. Gsk PLC Transaction History

Harbour Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $127,453 - $144,790	-3,031 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$38.88 - $45.31 $339,344 - $395,465	-8,728 Reduced 74.22%	3,031 $134,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $140,419 - $156,239	-3,620 Reduced 23.54%	11,759 $449,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $18,004 - $20,439	-493 Reduced 3.11%	15,379 $612,000
Q1 2021 Aug 17, 2021	BUY	$34.27 - $40.01 $506,510 - $591,347	14,780 Added 1353.48%	15,872 $566,000
Q1 2021 May 12, 2021	BUY	$34.27 - $40.01 $37,422 - $43,690	1,092 New	1,092 $39,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.